March 10, 2016
…Study, the Center for Cannabis Research, the Type 1 Diabetes Research Center, the Musculoskeletal Science Center, the Center for Multimodal Imaging and Genomics and the departments of gastroenterology, hepatology and ophthalmology. “This is a 21st century lab,” said Dr. David Brenner, Vice Chancellor of Health Sciences and Dean of the…
June 10, 2024
Americans’ interest in the potentially harmful “magic mushroom” Amanita muscaria is soaring, according to a new study. UC San Diego researchers suggest the market growth may be driven by clinical research on psilocybin’s safety and efficacy in treating depression.
April 18, 2019
…on HIV and medicinal cannabis. Read More… Nineteen-hundred-and-sixty-nine was a famously memorable year. It was the year of Woodstock and the first man on the moon, of the Cuyahoga River in Cleveland catching fire and the last public performance by The Beatles—an impromptu concert atop Apple Records in London. It…
September 25, 2012
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
November 6, 2019
The University of California San Diego has announced its 2019 Entrepreneurs in Residence cohort. The EIR program brings outside expertise onto campus to help student and faculty entrepreneurs with their startups.
